107.521 articles found

[Metabolic activation of azaheterocyclics induced dopaminergic toxicity: possible candidate neurotoxins underlying idiopathic Parkinson's disease].

Matsubara K.

Nihon Hoigaku Zasshi · 1998-10-01

PMID: 10077975

Fatal attractions: abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia.

Trojanowski JQ, Goedert M, Iwatsubo T, Lee VM.

Cell Death Differ · 1998-10-01

DOI: 10.1038/sj.cdd.4400432PMID: 10203692

[Microelectrode-guided posteroventral pallidotomy for Parkinson's disease: clinical study of 100 cases].

Li Y, Iacono R.

Zhonghua Wai Ke Za Zhi · 1998-10-01

PMID: 11825475

Differential contributions of cognitive and motor component processes to physical and instrumental activities of daily living in Parkinson's disease.

Cahn DA, Sullivan EV, Shear PK, Pfefferbaum A, Heit G, Silverberg G.

Arch Clin Neuropsychol · 1998-10-01

DOI: 10.1093/arclin/13.7.575PMID: 14590618

Axial synergies in parkinsonian patients during voluntary trunk bending.

Alexandrov A, Aurenty R, Massion J, Mesure S, Viallet F.

Gait Posture · 1998-10-01

DOI: 10.1016/s0966-6362(98)00026-5PMID: 10200403

Mental dysfunction in Parkinson's disease.

Wolters EC, Francot CM.

Parkinsonism Relat Disord · 1998-10-01

DOI: 10.1016/s1353-8020(98)00022-4PMID: 18591098

L-DOPA improves visuo-motor coordination in stable Parkinson's disease patients.

Hocherman S, Alexandrovsky L, Badarny S, Honigman S.

Parkinsonism Relat Disord · 1998-10-01

DOI: 10.1016/s1353-8020(98)00034-0PMID: 18591102

Contralateral hemi-parkinsonism and atypical tremor after stroke (a case report).

Milanov I, Bogdanova D, Georgiev D.

Parkinsonism Relat Disord · 1998-10-01

DOI: 10.1016/s1353-8020(98)00021-2PMID: 18591104

Body composition in Parkinson's disease: a study with dual-energy X-ray absorptiometry.

Revilla M, Jiménez-Jiménez F, Villa L, Hernández E, Ortí-Pareja M, Gasalla T, Rico H.

Parkinsonism Relat Disord · 1998-10-01

DOI: 10.1016/s1353-8020(98)00033-9PMID: 18591103

Long-term intracerebral infusion of fibroblast growth factors restores motility and enhances F-DOPA uptake in parkinsonian monkeys.

de Yébenes JG, Pernaute RS, Garrido JM, Rábano A, Albisua J, Rojo A, Mena MA, Ruíz PG, Jorge P, Correa C, Leenders K, Antonini A, Gunther I, Psylla M, Vontobel P.

Parkinsonism Relat Disord · 1998-10-01

DOI: 10.1016/s1353-8020(98)00025-xPMID: 18591105

Treatment of Depression in the Patient with Parkinson's Disease.

Chow TW, Cummings JL.

Clin Geriatr · 1998-10-01

PMID: 28529443

IMPROVEMENT IN TREATMENT OF PARKINSON'S DISEASE AND RELATED DISORDERS BY NOVEL FORMULATIONS OF THE COMBINATION CARBIDOPA-LEVODOPA

RUBIN Alan A..

· 1998-09-14